MedPath

Vojta Therapy in Multiple Sclerosis.

Not Applicable
Completed
Conditions
Multiple Sclerosis
Physical Therapy
Registration Number
NCT03887507
Lead Sponsor
NUMEN Foundation
Brief Summary

This Study evaluates the effectiveness of a Vojta locomotion reflex program as short-term automatic postural control in patients with Multiple sclerosis

Detailed Description

In two consecutive weeks two interventions will be conducted: Vojta group(A) and standard therapy group(B). The last one is based on balance exercises targeting core stability, Bobath concept and sensory strategies. In the Vojta group 5 sessions will be conducted for a duration of 2 weeks and the same will be realised on the standard group. In addition, during the study, a daily activity shall be prescribed in both groups: Vojta exercise during 20 minutes for group A and walking for 20 minutes in group B.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Final diagnosis of MS according to McDonald criteria.
  • Walkability with or without assistance (4.0 to 6.5 in EDSS) and dysfunctions defined by the inability to hold the tandem position for 30 seconds with the arms close to body.
  • Older than 18 years-old.
  • Escorted sessions, a family member or close person.
Exclusion Criteria
  • Phase outbreak or outbreak in the 3 months before the study.
  • Medication that prevents or limits the performance of the Locomotion reflex.
  • Participation in other studies during the conduct of this study.
  • Score inferior to 6 in the Abbreviated Mental Test that prevents understanding of the study consent or that limits the understanding of the test during its realisation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
10 metres walk2 weeks

This Test measures the speed during 10 meter walking at normal pace

Berg Balance Scale2 weeks

This test measures the automatic postural control. The Berg scale comprises 14 items (score included 0-4). The total scores can range from 0 (severely affected balance) to 56 (excellent balance).

Secondary Outcome Measures
NameTimeMethod
Tandem 6 metres test2 weeks

This test measures the balance when walking with one foot in front of the other

Trial Locations

Locations (1)

NUMEN Foundation

🇪🇸

Madrid, España, Spain

NUMEN Foundation
🇪🇸Madrid, España, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.